Page last updated: 2024-09-04

resiquimod and glycine

resiquimod has been researched along with glycine in 1 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(glycine)
Trials
(glycine)
Recent Studies (post-2010) (glycine)
4651431835,1637568,415

Protein Interaction Comparison

ProteinTaxonomyresiquimod (IC50)glycine (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.4852
Sodium- and chloride-dependent glycine transporter 1Homo sapiens (human)106
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.3253
Sodium- and chloride-dependent glycine transporter 2Homo sapiens (human)128

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Graham, BS; Johnson, TR; Rao, S; Seder, RA1

Other Studies

1 other study(ies) available for resiquimod and glycine

ArticleYear
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
    Vaccine, 2009, May-18, Volume: 27, Issue:23

    Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Cell Line; Glycine; Humans; Imidazoles; Immunity, Cellular; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Viruses; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Virulence

2009